Please tell your friends about federated social media site that speaks several fediverse protocols thus serving as a hub uniting them, hubzilla.eskimo.com, also check out friendica.eskimo.com, federated
macroblogging social media site, mastodon.eskimo.com a federated microblogging site, and yacy.eskimo.com an uncensored federated search engine. All Free!
NOTE: We are publishing events for the Week of Action to Free Georges Abdallah that are independently organized. For any information about these events, please contact the organizers, as Samidoun i…
Con la luz del día circulan imágenes de la destrucción causada por los misiles iraníes en Tel Aviv, pese a que la entidad sionista exigió a sus ciudadanos que no difundan imágenes de los lugares impactados por los misiles.
Israel hat in der Nacht auf Freitag Iran angegriffen. Nach israelischen Angaben griffen Kampfflugzeuge mehrere Ziele in der Islamischen Republik an. Dabei seien Militäreinrichtungen und Atomanlagen getroffen worden.
John Stockwell left the CIA when he decided that what they were doing was endangering national security not protecting it.John R. Stockwell (born 1937) is a ...
NOTE: We are publishing events for the Week of Action to Free Georges Abdallah that are independently organized. For any information about these events, please contact the organizers, as Samidoun i…
Fear of reprisal is an old and central narrative of colonialism. It's the idea that once a colonial project is entrenched, it *must* be continued or else the indigenous population will seek revenge upon the colonizers, as bad or worse than what the colonizers did. This narrative has been used to justify South African apartheid, the Gaza genocide, the Iraq War, the KKK, the Black and Tans, and the Great Replacement theory. And it's historically been proven false.
NOTE: We are publishing events for the Week of Action to Free Georges Abdallah that are independently organized. For any information about these events, please contact the organizers, as Samidoun i…
On 19 June 2025, the French Court of Appeal will convene to consider the request to release the Lebanese struggler for Palestine, Georges Ibrahim Abdallah, held as a political prisoner in French ja…
i feel like israelis on average are just really detestable people. i have never met an israeli that i liked and all of them online seem to be deranged blood thirsty animals
i'm sure *some* israelis are cool people, i just haven't met any. the prevailing ideology in israel seems to be radical talmudic zionism. if that's not true then some israelis should speak up and correct me
israel deserves a lot worse probably but let's keep in mind that innocent people are going to get hurt so, it's not something to enjoy. so i will stop enjoying it and just hope the whole thing fizzles
I don't know if this is true, you might have to look into it, but I've heard people say that Christianity is rising in Iran and could overtake Islam within a few years which could bring about a massive regime change.
http://vok.rep.kp/index.php/detail_com/comde/iee250527009/57/en / Politics – Devoted Service for the People’s Well-being The Samjiyon Theatre on the shore of the picturesque Pothong River is a live-sound theatre.
According to 2025 Nature Index, 13 of top 20 research institutions and 16 of top 20 research universities are Chinese.
China’s Nature Index score was 45% above second place US in 2024 after overtaking the US in 2023. Nature’s conclusions are confirmed by similar studies conducted by NISTEP, KISTI, and ASPI.
A description of the terminology and methodology used in this supplement, and a guide to the functionality that is available free online at natureindex.com.
@feyter there are other metrics such as citations, particularly the number of papers that fall into the top 1% or 10% of the most cited papers in their respective fields. The success rate in securing highly competitive grants. Surveys of academics globally who are asked to identify leading institutions in specific fields. The number of faculty members or alumni who have received major international scientific awards.The sheer size and qualifications of the research workforce.
I am a road cyclist, and I intend on getting a new bike soon. I'd like to use it to zoom around town for fun like I already do on my road bike, but I also want to be able to commute with it. As such, I'd like it to be able to handle light grass and dirt when I need to (no mud, gravel, excessive drops, etc). I've been thinking about a gravel or cross bike, but they're just not quite "zoomy" enough for me; I like more aggressive geometry and a nice, aero frame. Additionally, there has been a growing trend for thicker tires on road bikes, so a modern road bike should be able to fit cross tires. Should I just get a new road bike and throw some 33mm cross tires on it? Or should I suck it up and get a cross/gravel bike that's actually designed for dirt? On one hand I want to zoom and won't be on dirt/grass all that much, but on the other I don't want to ruin an expensive bike by taking it off-road when I shouldn't. Help a brother out.
"gravel bike" has been a widening category over the last few years. Some are basically road bikes with extra clearance (further confused by road bikes going that route too) all the way to essentially drop-bar hardtail mtbs. I'm pretty sure you would find a bike with the "gravel" label that's pretty aggressive while still being somewhat off-road capable. If you keep a second wheel set around, you can even convert it to a quasi road bike pretty easily.
تدعوكم الحملة الوطنية لتحرير جورج إبراهيم عبدالله وشبكة صامدون للدفاع عن الأسرى الفلسطينيين والاتحاد الطلابي العام، لحضور عرض فيلم “فدائيين”، الذي يتناول سيرة المناضل اللبناني الأسير …
"In the last 50 years, two-thirds of all wild animal populations have been lost."
As livestock numbers grow, wild animal populations plummet. Giving all creatures a better future will take a major rethink theconversation.com/as-livesto…
Glyphosate: une nouvelle étude confirme le risque de cancer
Une étude scientifique menée sous l’égide de l’institut Ramazzini à Bologne, en Italie, et publiée jeudi dans la revue «Environmental Health», apporte de nouvelles preuves du caractère cancérogène de l’herbicide le plus utilisé au monde.
Une étude scientifique menée sous l’égide de l’institut Ramazzini à Bologne, en Italie, et publiée jeudi dans la revue « Environmental Health », apporte de nouvelles preuves du caractère cancérogène de l’herbicide le plus utilisé au monde.
Nora Barrows-Friedman, associate editor, delivers the latest news from across the Gaza Strip.
This is a segment from The Electronic Intifada's livestream on day 615 of the Gaza genocide. Nora Barrows-Friedman, Jon Elmer and Asa Winstanley were joined by Francesca Albanese, UN Special Rapporteur on the occupied Palestinian territories. You can watch the full show here:
Your gift supports The Electronic Intifada's independent journalism on Palestine: • Donate by credit card, ApplePay, PayPal, Venmo or US bank account via Kindful: bit.ly/EIKindful
Gifts are welcome from anywhere and are tax-deductible for US taxpayers as allowed by law.
Podcast · The Electronic Intifada · The Electronic Intifada podcast is a weekly summary of the top stories featured on The Electronic Intifada, plus exclusive interviews with newsmakers, analysts and activists.
@Flat Moon Theories I'm not against taking action against Cartels but I think a more surgical approach is warranted, bombing tends to be rather indiscreet.
@Sherri_Ingrey I disagree, Netanyahu was leader of Israel for a while, all sorts of wars and has no problem slaughtering innocents. then he wasn't and while there weren't as many wars and Israel was less aggressive, there still were wars, and now he's back and ramping up the destruction to the point of outright genocide.
Revolution in Warship-building Industry in New Era and Vigorous Advance and Development in Modernization of Naval Forces Ceremony of Launching Destroyer of KPA Navy Takes Place with Splendor #DPRKkfauk.com/revolution-in-warshi…
Pyongyang, June 13 (KCNA) — The firm faith and steadfast revolutionary will of the Workers’ Party of Korea to firmly defend the long-term development of the prosperity and flourish of our great state with its strong, matchless and absolute strength a…
Four men, including a government contracting officer for the United States Agency for International Development (USAID) and three owners and presidents of companies, have pleaded guilty for their roles in a decade-long bribery scheme involving at lea…
Switzerland 🇨🇭 is debating a major surveillance law overhaul that could force VPNs, email, and messaging providers to collect more user data and weaken online anonymity. Critics warn it threatens privacy and digital freedom. What’s at stake? Read more: techradar.com/vpn/vpn-privacy-… #Privacy #Surveillance #Switzerland #VPN #Proton
In Alex and Paul Cannon’s comedic short, starring Chris Gethard, a dad struggles to give an age-appropriate explanation of the expletive. See more are https://www.newyorker.com/video
General Lewis Burwell "Chesty" Puller quotes and quotations. Regarded as one of the greatest US Marines legends and highest decorated Marine in history
Si bien la vida en Israel se paralizó este viernes por el ataque a Irán, con el país anunciando una situación de emergencia, cerrando escuelas y sinagogas y limitando el transporte público, la vida en Gaza no ha cambiado mucho, con Israel todavía ata…
Alberta's measles outbreaks are now the worst in nearly half a century | CBC News cbc.ca/news/canada/calgary/alb… “Alberta's measles surge is so dramatic, the last time case counts were higher Calgary did not have an NHL team, O Canada was not yet the official national anthem and gasoline would set you back 24 cents a litre.”
I honestly don't understand the whole "nukes are fake" conspiracy theory. It sounds even dumber than flat earth.
Seriously, how can they cover up Hiroshima and Nagasaki if those explosions were fake. People who were near the alleged blast zones would've called bullshit on it.
Now I am open to the idea that the technology hasn't improved much (if at all) since those two bombs, and the threat of nuclear war is just a psyop to get everyone to accept the idea of a one world government as the only solution to save humanity from itself. Shit like the Doomsday Clock looks like fearmongering for that exact purpose, but to suggest that nuclear bombs have never existed is a bit of a stretch.
@Mr_NutterButter >why wouldn't the Soviets the sworn enemy of the United States not call the United States out if it was fake that would have done irreparable damage to the United States reputation and bolster the Soviets.
The Soviet Union was dependent on the US for wheat during that time. If the Soviet Union called out the US for faking the moon landing, then the US could simply cut off that deal.
Also, the true nature of relationships between countries is NOT what is shown to the public. China is supposed to be one of America's worst enemies, yet both countries participated in the Event 201 exercise just mere weeks before the COVID-19 outbreak in Wuhan.
@matthew also there are many reasonable explanation as to why Israel will be fear mongering, saying they're only 6 months away from making it
1. Just fear mongering to get their way politically.
2. To hammer in the idea and justification to strike them preemptively.
3. The people who are making the weapon are incompetent especially so considering, they barely have a functioning country to begin with.
4. Due to the constant sabotage they've been continually set back again and again and again.
5. Israel's Intel was very always giving the higher up's bad Intel in hopes of a preemptive strike or false flag, because they have their own secret goals.
A quote from a fictional character for some reason.
"There's a reason you separate military and the police. One fights the enemies of the state. The other serves and protects the people. When the military becomes both, then the enemies of the state tend to become the people" -- Commander Adama, Battlestar Galactica (2003 TV series)
Trump ICE regime forces are kidnapping former Afghan translators that risked their lives to help the US. The regime in coordination with corrupt judges is entrapping people. When they show up to hearings the corrupt judges dismiss their cases quickly to allow ICE to snatch the victims. #3E #StopICE
German Federal Office for the Protection of the Constitution (= domestic intelligence agency in Germany) classified Jewish Voice for Peace #Germany and other Palestine solidary groups as "definitely extremist".
(in German) Zur Einstufung der Jüdischen Stimme und BDS als “gesichert extremistisch” durch den Verfassungsschutz (Jüdische Stimme für gerechten Frieden in Nahost, 2025-06-12)
Jedeed doesn't mention a notable earlier use of the phrase "police riot" in the US. So let me inject a bit of history.
I remember the violence in the streets at the 1968 Democratic National Convention in Chicago. thecollector.com/chicago-riots…
I was even indoors at the convention at the time. My step-father was a delegate and I attended on a guest pass.
The National Commission on the Causes and Prevention of Violence asked Dan Walker to lead an investigation into the violence. He and 200 staffers studied film footage, reviewed FBI reports, and interviewed more than 1,400 witnesses. In the end, the "Walker Report" referred to the police violence against protesters, journalists, and bystanders as a "police riot". archive.org/details/rightsinco…
Walker was no radical. He was a Naval officer, Korean War vet, executive at Montgomery Ward, campaign chair for Adlai Stevenson III, and Governor of Illinois, 1973-77. en.wikipedia.org/wiki/Dan_Walk…
Multiple protest movements combined during the summer of 1968 in Chicago, erupting in the Chicago Riots at the Democratic National Convention, where the party nominated a non-candidate for president.
Palestinian news agency Wafa is reporting that three children were among those injured as rocket shrapnel fell near the town of Sa’ir near Hebron in the southern West Bank.
The five injured people – including the children, aged six, seven and 12 – were taken to hospital, according to Wafa, which cited the Palestine Red Crescent Society.
I'm guessing that's not it. I'm also on mastodon.online and have been on continuously for the last 3 hours and I have seen no interruption in service at all.
@johnb48 Today the service stopped very briefly. So you wouldn't notice it unless you posted something during the few seconds of down time. But yesterday, around the same time, the service was down for hours. I wonder if you were also using it yesterday around this time of the day.
Sure enough. Most often I think the maintenance window is between around 0100 and 0300. I assume that the server is in the EU somewhere which makes that maybe a reasonable consideration?
Well, it's 10:00 p.m. here which would be 4:00 a.m. in the UK and 5:00 a.m. in most of the EU. And to me, that would stretch to the very very far edge of what somebody could call a maintenance window.
It's interesting that there's that smaller peak before the big one. I suppose that I could think of 50 reasons for that but not knowing what really caused that, I guess that's a useless exercise.
It could indeed be because of scheduled maintenance activities in a time window that is convenient in Europe ... Or increased load at a time when people in the West coast are active and complaining about ICE 🙂
Truth Social is America's "Big Tent" social media platform that encourages an open, free, and honest global conversation without discriminating on the basis of political ideology.
Industry sources reveal drug companies have stopped negotiating listings on the PBS and in some cases are considering not listing in Australia as they seek to lift profits under Trump. By Jason Koutsoukis. Exclusive: PBS listings frozen over Trump’s executive order
<<Australia’s Pharmaceutical Benefits Scheme has been effectively frozen since May, after United States President Donald Trump issued an order to change how pharmaceutical companies price drugs.
Industry sources say drug companies have stopped listing new medicines with the scheme, hoping Trump’s order will allow them to lift prices for Australia.
At the centre of the dispute is Trump’s May 12 executive order reviving his controversial “Most Favored Nation” pricing proposal, a populist idea floated during his first term.
The premise is simple: the United States should pay no more for medicines than the lowest price paid by peer nations. In a globalised pharmaceutical market, the proposal could curtail Australia’s access to cheaper medicines.
By linking US prices to those in countries such as Australia – where the federal government uses rigorous health technology assessments to drive hard bargains with drug companies – Trump’s policy threatens to upend the commercial logic of launching new drugs in smaller, lower-priced markets.
“We are hearing that in the headquarters of companies, that they are having this conversation about the US’s Most Favored Nation policy and what that flow-on effect would have across the world,” says Sue MacLeman, chair of Medicines Australia, the pharmaceutical industry’s peak representative body.
“And companies may delay application for both product registration in Australia through the Therapeutic Goods Administration, and also reimbursement through the PBS of new medicines as they seek to avoid us referencing to prices that undervalue innovation and affect global prices.”
If Australian PBS prices become a global benchmark – not just in Europe and the Asia-Pacific, but for US health insurers – drug companies may simply stop offering Australia competitive deals. Worse, they may not offer the product at all.>>
<<Some of that effect is already visible, with industry sources saying there is evidence that pharmaceutical companies are pausing pricing approvals for new PBS listings, and in some cases reconsidering whether to apply for market authorisation at all, wary that Australia’s low published prices could be used against them in US negotiations.
“We also could see some medicines withdrawn from the Australian market to actually avoid detrimental pricing sequences,” MacLeman says. “And so, from our perspective, there will be a potential flow-on effect to Australia, and we may find that Australians will miss out on new medicines, and that it may have an impact on our very vibrant life sciences ecosystem.
“Because these innovative medicines companies will make decisions about where they’re going to invest and that could include not only the approval of medication and the reimbursement of medication but also where they do their clinical trials and where they invest in the education of our clinicians and provide healthcare.”
Another industry insider described the response from pharmaceutical companies as “not coordinated but cautious”. They said it was “more of a defensive crouch in a system where pricing in one market can now threaten revenue in another”.
“It’s a wait-and-see approach,” one Australian pharmaceutical executive tells The Saturday Paper. “But every delay could mean that someone here goes without treatment.”
Last week, Australian pharmaceutical industry trade publication BioPharmaDispatch reported that global pharmaceutical companies have imposed a pause on pricing approvals, including for new PBS listings, while the industry builds its understanding of the implications of Trump’s executive order.
According to BioPharmaDispatch, these delays are being compounded by the increasing resistance of health department officials to approve special pricing arrangements, under which pharmaceutical companies rebate the difference between the published price for medicines and the private price that the Australian government is actually prepared to pay.>>
<<These arrangements, BioPharmaDispatch reported, have been a common feature of PBS pricing policy for more than a decade and are considered crucial to ensuring Australia’s access to innovative medicines.
“If we’re paying more for medicines, it does ultimately mean either we’re taxing people more or ... we are forgoing something else such as giving hospitals less money.” In 2023-24, there were 930 different medicines and 5164 brands listed on the PBS, costing the government $17.7 billion. Over the same period the pharmaceutical industry collectively paid back more than $5.3 billion in rebates to the Australian government, nearly 30 per cent of the total cost of the PBS.
Further delays in new drugs being listed on the PBS would place pressure not only on patients waiting for subsidised access to new treatments but also on the Albanese government’s ability to defend the integrity of Australia’s flagship medicines subsidy program amid rising geopolitical and commercial headwinds.
At the National Press Club on Tuesday, Prime Minister Anthony Albanese signalled he would stand firm in the fight over who pays for pharmaceutical innovation – and to defend the PBS from external interference.
Albanese is expected to have his first face-to-face meeting with Trump on the sidelines of the G7 summit next week. Asked whether he would walk away from the meeting if he didn’t like the deal on offer, he replied: “On things like the Pharmaceutical Benefits Scheme, the media bargaining code, our biosecurity in agriculture – they’re not on the table as far as we’re concerned.”
Take one example. Donanemab, a new treatment for early stage Alzheimer’s disease developed by US multinational Eli Lilly, is already approved for use by Australia’s Therapeutic Goods Administration but has not been listed on the PBS.
Health Minister Mark Butler revealed last month that the Pharmaceutical Benefits Advisory Committee, which determines the advice to government about which medicines end up on the PBS, will be considering Donanemab in July.
Before the drug can be listed on the PBS, Eli Lilly’s global head office would have to approve the price offered by the Australian government.
“Lilly believes there needs to be a serious conversation about the medicine reimbursement process in Australia, to ensure the PBS is enabling people to access new medicines,” Tori Brown, general manager Lilly Australia and New Zealand, tells The Saturday Paper. “Australians deserve a medicines evaluation system reflecting 21st century pharmaceutical innovation – which is why Health Minister Butler has instigated a review of the PBS. Despite Australia’s high GDP per capita, our reimbursed medicine prices are amongst the lowest globally. The low pricing of medicines in Australia does not reflect the value of innovative medicines or fairly contribute to research and development costs.”>>
<<US drug companies have long opposed schemes like the PBS, which delivers some of the lowest medicine prices in the developed world. They argue that the PBS systematically drives down what they can charge, undermining global pricing power and limiting their ability to recoup the high costs of research and development.
On Monday, Albert Bourla, chairman and chief executive of US pharmaceuticals giant Pfizer, told Goldman Sachs’s global healthcare conference that he was hoping Trump’s Most Favored Nation pricing proposal would deliver cheaper medicines for US consumers on the one hand and, conversely, an increase in international drug prices.
Asked whether governments in Europe and the United Kingdom, which employ subsidy programs similar to Australia’s, could pay more for medicines, Bourla was adamant that they could.
“Yes, they can increase prices,” Bourla said. “Are they willing to do it? Of course not. They don’t. They are having, let’s say, free-riding, all these years, and they want to continue that.”
Bonny Parkinson, associate professor at Macquarie University’s Centre for the Health Economy, says it’s no surprise pharmaceutical companies are delaying new listings on the PBS in response to the uncertainty triggered by Trump’s May 12 order.
Each submission to the Pharmaceutical Benefits Advisory Committee requires a substantial investment of time, data and resources, she notes, making companies wary of proceeding while global pricing rules remain in flux.
“Our own research has said, on average, it costs about $830,000 per submission,” Parkinson tells The Saturday Paper. “So yeah, it is a large investment and if there’s going to be uncertainty here, it makes sense that maybe you would want to hold back on putting in and spending that money until the environment is a little bit more known.”
In the end, says Parkinson, the whole PBS process is like one big, protracted negotiation.
“I think the government does have to weigh up how much they’re willing to spend on medicine versus other parts of the healthcare system but also other demands for taxpayer-funded services,” says Parkinson.
“So the reality is that there are trade-offs. There probably is some capacity in the system to pay a little bit more, but if we’re paying more for medicines, it does ultimately mean either we’re taxing people, the Australian population, more or, alternatively, we are forgoing something else such as giving hospitals less money or forgoing preventative healthcare services.”
Still, in the view of Griffith University Professor Paul Scuffham, one of Australia’s leading health economists, the price Australia pays for drugs listed on the PBS is fair.>>
<<“I think we are paying our way. Big pharma have an international price that they disclose and make explicit, and that’s the price that they want to seek in every country when it comes to negotiations for government reimbursement,” says Scuffham. “But they also have a pricing negotiation agreement that is confidential commercial-in-confidence. So we need to know what [are] the true prices that we are paying, what the government pays for those drugs.”
If the Trump administration adds Australia to its Most Favored Nation pricing basket – using PBS-listed prices to benchmark what the US pays for medicines – there may be little Australia can do to stop it. The US doesn’t need Australia’s consent. It can unilaterally include any country whose prices are public and accessible, and Australia’s PBS is among the most transparent in the world.
That makes Australia an easy target – and a politically convenient one – for a US administration intent on forcing allies to share more of the cost burden for both security and pharmaceutical innovation.
What can Australia do in response?
Not much, says Medicines Australia chair Sue MacLeman. “This is their domestic policy,” she says. “We try not to comment on another country’s internal decisions – but that doesn’t mean they don’t have global consequences.”
MacLeman is focused on other solutions, particularly the urgent need to modernise Australia’s own health technology assessment system.
A major review commissioned by Health Minister Butler as part of the government’s 2022-2027 Strategic Agreement with Medicines Australia delivered 50 recommendations last year, aimed at overhauling Australia’s health technology assessment system.
Chaired by Professor Debora Picone, the review examined how new medicines and health technologies are evaluated for public funding – with a focus on ensuring faster, fairer and more transparent access for Australian patients.
While an implementation group, comprising government officials, industry representatives, clinicians and patient advocates, is now working on the reforms, for MacLeman the case for prioritising those changes is clear.
“They would ensure medicines are more appropriately valued, speed up access and make Australia a more attractive market for new launches,” she says.
Some measures, such as lowering discount rates or introducing a bridging fund for innovative therapies could be implemented quickly without legislation.
Done well, MacLeman believes these reforms could even help “take the heat out of the conversation with the US” and signal to the Trump administration that Australia is willing to evolve – on its own terms.
This article was first published in the print edition of The Saturday Paper on June 14, 2025 as "Exclusive: PBS listings frozen over Trump’s executive order".
100% … also applies here. the more things change, the more they stay the same.
this excerpt is about the statute of labourers 1350
<<As a result of these statutes, there was a cap on wages; prohibitions on quitting; and geographical limits on where work could be sought. The alter- native for the worker was prison. The regulation of the nonworking poor depended completely on whether the poor person was able to work. If they were able to work, the choice was work at the wages offered or prison. If they could not work, then they were not prohibited from begging. While these laws continued to be modified by later laws, examination of these statutes show comprehensive regulation of the working and the nonworking poor.9' Indeed, the concerns for beggars and laborers were intertwined: "[t]he King and his lords saw begging, movement and vagrancy, and the labor shortage as essen- tially the same problem, to be dealt with in one law .... The beggar, in the concern of the Statute of Laborers, was not a problem in destitution but a seepage from the supply of labor.">>
from five hundred years of english poor laws 1349-1834 Regulating the Working and Nonworking Poor Professor William P. Quigley 30 Akron L. Rev. 73 (1996)
Egyptian security forces stood by as dozens of pro-Palestinian activists, who arrived in Cairo to participate in the Global March to Gaza, were assaulted.Cat...
certainly not but thats part of the goal. another example for the world to see and to put pressure on their respective governments to stand up for their own citizens. this video specifically is also really important for people who don't understand the dynamic to see. the arab governments, egypt first and foremost, dont really oppose israel. their so subservient to the cause they'll beat their own citizens and the citizens of other countries on israel's behalf. $4B a year can buy you a lot of soldiers.
Trans Tik Toker, Lily Tino, baits innocent restaurant workers into misgendering himself, in use of trying to embarass them, meanwhile, only embarassing himself.
An informed Iranian source announced Friday morning that a plan is being developed for a decisive response to the recent attacks launched by the Zionist entity on Tehran and several other cities in the country.
:hoshino_wow:
in reply to LoliHat • • •